Asia Pacific market to enhancethe demand for intrauterine contraceptive devices
Asia Pacific is expected to holda significant share for IntrauterineContraceptive Devices Market owing to the rising number of unplannedpregnancy and thereby, greater usage of such devices in this region. Moreover,rising government initiatives focusing on improved healthcare in Asiancountries are also supporting the growth of the market. Furthermore,technological advancements associated with these devices are accentuating theirdemand in North America, followed by Europe.
Some of the major companiesindulging in the production of intrauterine contraceptive devices include BayerHealthCare AG, Melbea AG, DKT International, Medicines360 and EgemenInternational among others. These companies are focusing on strategic initiativesand mergers and acquisitions in order to cater to the growing need of thetarget population. For instance, in 2015, Bayer HealthCare entered into astrategic partnership with Afaxys, Inc. in order to serve women in the U.S. Thealliance will include Afaxys’ expertise and Bayer’s intrauterine device toserve the U.S. public health contraception market.
Intrauterine contraceptivedevices - a way of birth control for a prolonged period
Intrauterine contraceptivedevices (IUD), often found in T-shape, are inserted in the uterus in order toprevent conception. The arms of the device are fold flat helping to insertinside the womb and its size is like a match stick, so that it fits properlyinside the womb. These devices include either copper or levonorgestrel, whichhelps in birth control by creating difficulty for the sperm to fertilize theegg. Intrauterine contraceptive devices are usually a form of long-actingreversible contraceptives (LARC), which aids in birth control for an extendedperiod of time. The approximate tenure of these devices lie between 5 to 8years. These devices have resulted in huge satisfaction rates among the usersof reversible contraceptives due to their cost-effectiveness. Copper IUD isalso used after an unprotected sex as an emergency contraceptive. Intrauterinecontraceptive devices do not have a negative impact on breastfeeding, when theyare inserted immediately after delivery. These are also used immediately afterabortion. Once removed, fertility is restored back to normal. These devices areinserted with the help of healthcare professionals. According to an articlepublished by Patient, a web-based health information platform, IUDs are veryeffective as 1 to 2 out of every 100 women will become pregnant after 5 yearsof using the device. The non-users of this device, who are sexually active,become pregnant and the count reaches to 80 out of 100 women within 1 year.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/53
Unplanned pregnancy is a majordriver for intrauterine contraceptive devices
Rising prevalence of unplannedpregnancy and less side-effects pertaining to these devices are some of thedrivers impacting the demand for intrauterine contraceptive devices market.Moreover, with the use of such devices there is no requirement of a newcontraception every day, as in case of contraceptive pills. Moreover,intrauterine contraceptive devices do not impact the user’s mood, libido andweight and does not even carry the risk for cancer in future. However, use ofintrauterine contraceptive devices may lead to heavy menstrual bleeding,resulting into painful cramps, which is projected to impede the growth of themarket. In addition, the demand for contraceptive pills for shorter periodusage is expected to hinder the demand for the devices. Need for continuousassistance of healthcare professionals is also restraining the market towardsgrowth.
Hormonal IUCD has low failurerate as compared to copper IUD
On the basis of product,intrauterine contraceptive devices (IUD) are segmented as hormonal IUD andcopper IUD. In the first year of usage of the device, failure rate with hormonalIUD is around 0.2% whereas failure rate with copper IUD is around 0.8%.
On the basis of end use,intrauterine contraceptive devices are classified under hospital, gynecologyclinics and others. Based on geography, the market is divided into North America,Europe, Asia Pacific, Latin America and Middle East and Africa.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/intrauterine-contraceptive-devices-market-53
Key Developments
Focus on women’s health andguidelines by regulatory authorities is driving the market growth. Forinstance, in August 2019, the World Health Organisation (WHO) revised itsguidelines on contraceptive use in accordance with new evidence regarding highrisk of HIV in women. The new guidelines state that women should have access toa range of options for contraception, HIV prevention, and treatment, such asprogestogen-only injectables, implants and intrauterine devices (IUDs).
Promotion strategies and educationalcampaigns undertaken by key players in the market are expected to increasehealth awareness among consumers, which, in turn, is expected to result inrising demand for IUDs. For instance, in February 2019, Bayer HealthCare AGstarted the first ever ad campaign regarding intrauterine devices (IUDs). Thegoal of the campaign is to explain the purpose of levonorgestrel-releasingIUDs, and also provide basic knowledge about these devices.
Similarly, social marketingprograms by market players aimed at providing family planning and HIVprevention solutions to women and couples in low and middle income countriesare facilitating growth of the global intrauterine contraceptive devicesmarket. According to DKT International’s Contraceptive Social Marketing (CSM)Statistics report released in October 2018, there has been a 6.8% increase from2016, and a nearly 18% increase from 2015 in sale of nearly 1.8 billioncondoms, 44 million injectable contraceptives, nearly 1.4 million implants,over 17.3 million emergency contraception (EC) pills, and 5.1 million IUDs.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/53
AboutCoherent Market Insights:
Coherent MarketInsights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
